Stephen Haworth
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Stephen Haworth is Chief Medical Officer at XORTX Therapeutics, Inc. since 2021.
Former positions include Executive Director-Medical at CorMedix, Inc. from 2017 to 2018, Chief Medical Officer & Vice President at Elusys Therapeutics, Inc. from 2012 to 2013, and Vice President at VaxInnate Corp.
from 2015 to 2016.
Education includes undergraduate studies at University College London and a doctorate from UCL Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| XORTX THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/07/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
| CORMEDIX INC. | Directeur Technique/Scientifique/R&D | 01/01/2018 |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Directeur Technique/Scientifique/R&D | 01/04/2013 |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Corporate Officer/Principal | 01/04/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Health Technology |
CorMedix, Inc.
CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Health Technology |
UCL Medical School
UCL Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XORTX Therapeutics, Inc.
XORTX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national